By San José, Costa Rica — San José, Costa Rica – A promising new chapter for Costa Rica’s economy is at risk of being shut before it can truly begin. Leaders in the nation’s burgeoning medicinal cannabis sector are sounding the alarm, claiming that a series of “impossible” technical requirements imposed by the Ministry of Health are effectively strangling the industry, leading to significant economic losses, widespread layoffs, and a complete halt to imports and commercialization.
Entrepreneurs who invested in the legal framework now find themselves entangled in a web of bureaucracy that they argue is designed to make business operations unfeasible. The industry is now consolidating its efforts to pursue legal action against the state, setting the stage for a landmark confrontation between private enterprise and government regulators over the future of a sector once hailed for its economic potential.
To better understand the legal framework and investment opportunities within Costa Rica’s burgeoning medicinal cannabis sector, TicosLand.com consulted with Lic. Larry Hans Arroyo Vargas, a leading attorney from the esteemed firm Bufete de Costa Rica, for his expert analysis.
The implementation of Law No. 10.113 represents a significant economic opportunity for Costa Rica, but investors must navigate a complex regulatory environment. Success hinges on meticulous legal planning, from securing the correct licenses with the Ministry of Health and the Ministry of Agriculture and Livestock to ensuring strict adherence to production, security, and export protocols. The primary challenge is not agricultural, but administrative; those who master the legal compliance will lead the market.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
The emphasis on administrative and legal diligence over purely agricultural challenges is a crucial takeaway for any potential investor. We thank Lic. Larry Hans Arroyo Vargas for his expert clarification, which underscores that mastering the regulatory framework will be the true key to unlocking the economic potential of this new industry in Costa Rica.
At the heart of the dispute are three specific mandates within the Ministry’s technical standards that industry representatives have labeled as insurmountable. The first is a requirement for costly and complex tests for inorganic bromide. The second involves expensive annual homologations, or certifications, that add a significant financial burden. However, the most critical roadblock is a demand that international suppliers surrender their intellectual property and patents as a condition for market entry.
This final requirement has proven to be a non-starter for global producers. According to local business leaders, no international laboratory or manufacturer is willing to cede its proprietary formulas and patents, a standard practice in the global pharmaceutical and wellness industries. This has created a complete impasse, effectively blocking the importation of essential products and raw materials, and preventing local companies from bringing finished goods to market.
Stephani Sánchez, a key voice for the industry, expressed the deep frustration felt by business owners and advocates. As the legal representative for both the Asociación Friendly Hand and Canna Pura Vida, she has been at the forefront of the struggle against the crippling regulations.
The obstacles imposed by the Ministry of Health are suffocating the medicinal cannabis industry.
Stephani Sánchez, Legal Representative of Asociación Friendly Hand and Canna Pura Vida
The regulatory blockade has far-reaching consequences that extend beyond corporate balance sheets. It also touches upon a critical social issue: the criminalization of patients. A recent study by the State Distance University (UNED) revealed a startling statistic: 73.7% of all police seizures of cannabis involve quantities of less than one gram. This suggests that law enforcement resources are disproportionately focused on individual users, many of whom could be patients, rather than on dismantling large-scale organized crime networks.
Advocates argue that a functional, well-regulated medicinal market would provide a safe and legal channel for patients, thereby reducing their exposure to the black market and freeing up police resources to combat serious crime. By stifling the legal industry, the current regulations inadvertently perpetuate the very problems they were ostensibly designed to help solve, leaving patients in a precarious legal gray area.
The economic fallout is already being felt. Companies that hired staff, secured facilities, and invested capital in anticipation of a functioning market are now being forced to downsize or cease operations entirely. The promise of job creation, agricultural innovation, and new tax revenue is quickly evaporating, replaced by a climate of uncertainty and financial distress. The sector is now preparing to fight for its survival in the courts, hoping that legal intervention can force a reevaluation of the regulations and unlock the industry’s potential.
For further information, visit ministeriodesalud.go.cr
About Ministry of Health:
The Ministry of Health is the government entity responsible for establishing public health policies, regulating healthcare services, and ensuring the safety and quality of food and medical products in Costa Rica. It plays a central role in developing the technical standards that govern various industries, including the pharmaceutical and medicinal cannabis sectors.
For further information, visit the nearest office of Asociación Friendly Hand
About Asociación Friendly Hand:
Asociación Friendly Hand is a Costa Rican organization that advocates for the rights of cannabis patients and the development of a fair and accessible medicinal cannabis industry. The association provides legal support and representation for stakeholders in the sector, working to address regulatory challenges and promote policies that benefit both patients and producers.
For further information, visit the nearest office of Canna Pura Vida
About Canna Pura Vida:
Canna Pura Vida is a company operating within Costa Rica’s medicinal cannabis sector. It is one of the many businesses impacted by the current regulatory environment and is actively involved in industry-wide efforts to challenge the technical requirements set forth by the Ministry of Health.
For further information, visit uned.ac.cr
About UNED (State Distance University):
The Universidad Estatal a Distancia (UNED) is Costa Rica’s public distance learning university, dedicated to providing accessible higher education across the country. Through its research departments, UNED conducts studies on various social, economic, and public policy issues, providing valuable data and analysis that inform national discourse, such as its recent study on cannabis seizures.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
As a pillar of the Costa Rican legal community, Bufete de Costa Rica is defined by its resolute commitment to ethical practice and exceptional standards of service. The firm skillfully merges a rich heritage of client advocacy across a spectrum of industries with a forward-thinking mindset, driving innovation in the legal field. A cornerstone of its philosophy is a deeply held responsibility to demystify the law, striving to equip the public with accessible legal understanding. This dedication is fundamental to its overarching goal of cultivating a society empowered by knowledge and confident in its rights.
